Free Trial

USANA Health Sciences (NYSE:USNA) Reaches New 12-Month Low - What's Next?

USANA Health Sciences logo with Medical background

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report)'s stock price hit a new 52-week low on Tuesday . The company traded as low as $31.10 and last traded at $31.35, with a volume of 8614 shares traded. The stock had previously closed at $31.64.

Analysts Set New Price Targets

USNA has been the subject of several recent analyst reports. StockNews.com upgraded shares of USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a report on Saturday, December 28th. DA Davidson increased their price target on USANA Health Sciences from $35.00 to $38.00 and gave the company a "neutral" rating in a research note on Thursday, January 2nd.

View Our Latest Research Report on USANA Health Sciences

USANA Health Sciences Stock Down 0.1 %

The stock has a market capitalization of $602.33 million, a P/E ratio of 11.17, a PEG ratio of 0.88 and a beta of 0.87. The firm's 50-day simple moving average is $35.61 and its 200 day simple moving average is $37.78.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Principal Financial Group Inc. grew its holdings in shares of USANA Health Sciences by 2.8% in the 4th quarter. Principal Financial Group Inc. now owns 53,603 shares of the company's stock worth $1,924,000 after acquiring an additional 1,480 shares during the last quarter. Rhumbline Advisers boosted its position in shares of USANA Health Sciences by 39.8% in the 4th quarter. Rhumbline Advisers now owns 49,390 shares of the company's stock valued at $1,773,000 after purchasing an additional 14,068 shares during the period. R Squared Ltd purchased a new position in USANA Health Sciences in the 4th quarter worth about $28,000. Pacer Advisors Inc. increased its stake in USANA Health Sciences by 8.8% in the 4th quarter. Pacer Advisors Inc. now owns 592,001 shares of the company's stock worth $21,247,000 after purchasing an additional 47,745 shares in the last quarter. Finally, Exchange Traded Concepts LLC raised its holdings in USANA Health Sciences by 11.3% during the 4th quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company's stock worth $308,000 after buying an additional 869 shares during the period. Institutional investors own 54.25% of the company's stock.

USANA Health Sciences Company Profile

(Get Free Report)

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

Featured Stories

Should You Invest $1,000 in USANA Health Sciences Right Now?

Before you consider USANA Health Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.

While USANA Health Sciences currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Stocks to Benefit From Trump’s Tariffs in 2025

7 Stocks to Benefit From Trump’s Tariffs in 2025

While the impact of these tariffs remains uncertain, some stocks are positioned to thrive under these policies; check out these 7 stock picks now.

Recent Videos

Palantir’s Explosive Growth: Buy Now or Wait for a Dip?
5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines